New Ovarian Cancer Drug Offers Hope, Longer Lives, and Better Quality of Life for Women
A groundbreaking new treatment for ovarian cancer is now available on the NHS, bringing fresh hope to hundreds of women across England. The drug, called mirvetuximab soravtansine, not only helps patients live longer but also significantly reduces many of the harsh side effects associated with traditional chemotherapy. Unlike conventional chemotherapy, which affects healthy and cancerous cells…